Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

324 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives.
Zelenetz AD, Ahmed I, Braud EL, Cross JD, Davenport-Ennis N, Dickinson BD, Goldberg SE, Gottlieb S, Johnson PE, Lyman GH, Markus R, Matulonis UA, Reinke D, Li EC, DeMartino J, Larsen JK, Hoffman JM. Zelenetz AD, et al. Among authors: markus r. J Natl Compr Canc Netw. 2011 Sep;9 Suppl 4:S1-22. doi: 10.6004/jnccn.2011.0136. J Natl Compr Canc Netw. 2011. PMID: 21976013
The use of pharmacometrics to optimize biosimilar development.
Dodds M, Chow V, Markus R, Pérez-Ruixo JJ, Shen D, Gibbs M. Dodds M, et al. Among authors: markus r. J Pharm Sci. 2013 Nov;102(11):3908-14. doi: 10.1002/jps.23697. Epub 2013 Sep 11. J Pharm Sci. 2013. PMID: 24027111
324 results